** Shares of medical equipment maker Bruker Corp BRKR.O down 9.1% to $30.20 post-market after planned capital raise news
** Massachusetts-based firm commences $600 mln 3-yr mandatory convertible preferred stock offering
** It says intends to use net proceeds to strengthen its balance sheet by fully repaying term loan due Dec 2026 and other outstanding debt
** JP Morgan and BofA are joint bookrunners for the offering
** BRKR shares on Tues closed down 2.2% at $33.23, extending YTD loss to 43%
** Co has ~$5 bln market cap, per LSEG data
** Of 15 analysts covering BRKR, recommendation breakdown is 7 "strong buy" or "buy", 7 "hold" and 1 "sell"; median PT is $43 - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))